Etoposide Plus Benmelstobart Followed by Maintenance Therapy of Benmelstobart Plus Anlotinib in First-line Treatment of Elderly Patients with Extensive Stage Small Cell Lung Cancer: a Single-arm, Prospective Trial
Clinical trial NCT06825208 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06825208
- Sponsor
- Nanjing First Hospital, Nanjing Medical University
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-02-01
- Primary completion
- 2027-06-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.